| ||||
Public Act 096-1078 | ||||
| ||||
| ||||
AN ACT concerning public aid.
| ||||
Be it enacted by the People of the State of Illinois,
| ||||
represented in the General Assembly:
| ||||
Section 1. Short title. This Act may be cited as the | ||||
Pediatric Palliative Care Act. | ||||
Section 5. Legislative findings. The General Assembly | ||||
finds as follows: | ||||
(1) Each year, approximately 1,185 Illinois children | ||||
are diagnosed with a potentially life-limiting illness. | ||||
(2) There are many barriers to the provision of | ||||
pediatric palliative services, the most significant of | ||||
which include the following: (i) challenges in predicting | ||||
life expectancy; (ii) the reluctance of families and | ||||
professionals to acknowledge a child's incurable | ||||
condition; and (iii) the lack of an appropriate, | ||||
pediatric-focused reimbursement structure leading to | ||||
insufficient community-based resources. | ||||
(3) It is tremendously difficult for physicians to | ||||
prognosticate pediatric life expectancy due to the | ||||
resiliency of children. In addition, parents are rarely | ||||
prepared to cease curative efforts in order to receive | ||||
hospice or palliative care. Community-based pediatric | ||||
palliative services, however, keep children out of the |
hospital by managing many symptoms in the home setting, | ||
thereby improving childhood quality of life while | ||
maintaining budget neutrality.
| ||
(4) Pediatric palliative programming can, and should, | ||
be administered in a cost neutral fashion. Community-based | ||
pediatric palliative care allows for children and families | ||
to receive pain and symptom management and psychosocial | ||
support in the comfort of the home setting, thereby | ||
avoiding excess spending for emergency room visits and | ||
certain hospitals. The National Hospice and Palliative | ||
Care Organization's pediatric task force reported during | ||
2001 that the average cost per child per year, cared for | ||
primarily at home, receiving comprehensive palliative and | ||
life prolonging services concurrently, is $16,177, | ||
significantly less than the $19,000 to $48,000 per child | ||
per year when palliative programs are not utilized. | ||
Section 10. Definition. In this Act, "Department" means the | ||
Department of Healthcare and Family Services. | ||
Section 15. Pediatric palliative care pilot program. The | ||
Department shall develop a pediatric palliative care pilot | ||
program under which a qualifying child as defined in Section 25 | ||
may receive community-based pediatric palliative care from a | ||
trained interdisciplinary team while continuing to pursue | ||
aggressive curative treatments for a potentially life-limiting |
illness under the benefits available under Article V of the | ||
Illinois Public Aid Code. | ||
Section 20. Federal waiver or State Plan amendment. The | ||
Department shall submit the necessary application to the | ||
federal Centers for Medicare and Medicaid Services for a waiver | ||
or State Plan amendment to implement the pilot program | ||
described in this Act. If the application is in the form of a | ||
State Plan amendment, the State Plan amendment shall be filed | ||
prior to December 31, 2010. If the Department does not submit a | ||
State Plan amendment prior to December 31, 2010, the pilot | ||
program shall be created utilizing a waiver authority. The | ||
waiver request shall be included in any appropriate waiver | ||
application renewal submitted prior to December 31, 2011, or | ||
shall be submitted as an independent 1915(c) Home and Community | ||
Based Medicaid Waiver within that same time period. After | ||
federal approval is secured, the Department shall implement the | ||
waiver or State Plan amendment within 12 months of the date of | ||
approval. By federal requirement, the application for a 1915 | ||
(c) Medicaid waiver program must demonstrate cost neutrality | ||
per the formula laid out by the Centers for Medicare and | ||
Medicaid Services. The Department shall not draft any rules in | ||
contravention of this timetable for pilot program development | ||
and implementation. This pilot program shall be implemented | ||
only to the extent that federal financial participation is | ||
available. |
Section 25. Qualifying child. | ||
(a) For the purposes of this Act, a qualifying child is a | ||
person under 18 years of age who is enrolled in the medical | ||
assistance program under Article V of the Illinois Public Aid | ||
Code and suffers from a potentially life-limiting medical | ||
condition, as defined in subsection (b). A child who is | ||
enrolled in the pilot program prior to the age 18 may continue | ||
to receive services under the pilot program until the day | ||
before his or her twenty-first birthday.
| ||
(b) The Department, in consultation with interested | ||
stakeholders, shall determine the potentially life-limiting | ||
medical conditions that render a pediatric medical assistance | ||
recipient eligible for the pilot program under this Act. Such | ||
medical conditions shall include, but need not be limited to, | ||
the following: | ||
(1) Cancer (i) for which there is no known effective | ||
treatment, (ii) that does not respond to conventional | ||
protocol, (iii) that has progressed to an advanced stage, | ||
or (iv) where toxicities or other complications prohibit | ||
the administration of curative therapies. | ||
(2) End-stage lung disease, including but not limited | ||
to cystic fibrosis, that results in dependence on | ||
technology, such as mechanical ventilation. | ||
(3) Severe neurological conditions, including, but not | ||
limited to, hypoxic ischemic encephalopathy, acute brain |
injury, brain infections and inflammatory diseases, or | ||
irreversible severe alteration of mental status, with one | ||
of the following co-morbidities: (i) intractable seizures | ||
or (ii) brainstem failure to control breathing or other | ||
automatic physiologic functions. | ||
(4) Degenerative neuromuscular conditions, including, | ||
but not limited to, spinal muscular atrophy, Type I or II, | ||
or Duchenne Muscular Dystrophy, requiring technological | ||
support. | ||
(5) Genetic syndromes, such as Trisomy 13 or 18, where | ||
(i) it is more likely than not that the child will not live | ||
past 2 years of age or (ii) the child is severely | ||
compromised with no expectation of long-term survival. | ||
(6) Congenital or acquired end-stage heart disease, | ||
including but not limited to the following: (i) single | ||
ventricle disorders, including hypoplastic left heart | ||
syndrome; (ii) total anomalous pulmonary venous return, | ||
not suitable for curative surgical treatment; and (iii) | ||
heart muscle disorders (cardiomyopathies) without adequate | ||
medical or surgical treatments. | ||
(7) End-stage liver disease where (i) transplant is not | ||
a viable option or (ii) transplant rejection or failure has | ||
occurred. | ||
(8) End-stage kidney failure where (i) transplant is | ||
not a viable option or (ii) transplant rejection or failure | ||
has occurred. |
(9) Metabolic or biochemical disorders, including, but | ||
not limited to, mitochondrial disease, leukodystrophies, | ||
Tay-Sachs disease, or Lesch-Nyhan syndrome where (i) no | ||
suitable therapies exist or (ii) available treatments, | ||
including stem cell ("bone marrow") transplant, have | ||
failed. | ||
(10) Congenital or acquired diseases of the | ||
gastrointestinal system, such as "short bowel syndrome", | ||
where (i) transplant is not a viable option or (ii) | ||
transplant rejection or failure has occurred. | ||
(11) Congenital skin disorders, including but not | ||
limited to epidermolysis bullosa, where no suitable | ||
treatment exists.
| ||
The definition of a life-limiting medical condition shall | ||
not include a definitive time period due to the difficulty and | ||
challenges of prognosticating life expectancy in children. | ||
Section 30. Authorized providers. Providers authorized to | ||
deliver services under the pilot waiver program shall include | ||
licensed hospice agencies or home health agencies licensed to | ||
provide hospice care and will be subject to further criteria | ||
developed by the Department for provider participation. At a | ||
minimum, the participating provider must house a pediatric | ||
interdisciplinary team that includes a pediatric medical | ||
director, a nurse, and a licensed social worker. All members of | ||
the pediatric interdisciplinary team must submit to the |
Department proof of pediatric End-of-Life Nursing Education | ||
Curriculum (Pediatric ELNEC Training) or an equivalent. | ||
Section 35. Interdisciplinary team; services. Subject to | ||
federal approval for matching funds, the reimbursable services | ||
offered under the pilot program shall be provided by an | ||
interdisciplinary team, operating under the direction of a | ||
pediatric medical director, and shall include, but not be | ||
limited to, the following: | ||
(1) Pediatric nursing for pain and symptom management. | ||
(2) Expressive therapies (music and art therapies) for | ||
age-appropriate counseling. | ||
(3) Client and family counseling (provided by a | ||
licensed social worker or non-denominational chaplain or | ||
spiritual counselor). | ||
(4) Respite care. | ||
(5) Bereavement services. | ||
(6) Case management. | ||
Section 40. Administration. | ||
(a) The Department shall oversee the administration of the | ||
pilot program. The Department, in consultation with interested | ||
stakeholders, shall determine the appropriate process for | ||
review of referrals and enrollment of qualifying participants. | ||
(b) The Department shall appoint an individual or entity to | ||
serve as case manager or an alternative position to assess |
level-of-care and target-population criteria for the pilot | ||
program. The Department shall ensure that the individual | ||
receives pediatric End-of-Life Nursing Education Curriculum | ||
(Pediatric ELNEC Training) or an equivalent to become | ||
familiarized with the unique needs and difficulties facing this | ||
population. The process for review of referrals and enrollment | ||
of qualifying participants shall not include unnecessary | ||
delays and shall reflect the fact that treatment of pain and | ||
other distressing symptoms represents an urgent need for | ||
children with life-limiting medical conditions. The process | ||
shall also acknowledge that children with life-limiting | ||
medical conditions and their families require holistic and | ||
seamless care.
| ||
Section 45. Period of pilot program. | ||
(a) The program implemented under this Act shall be | ||
considered a pilot program for 3 years following the date of | ||
program implementation or, if the pilot program is created | ||
utilizing a waiver authority, until the waiver that includes | ||
the services provided under the program undergoes the federally | ||
mandated renewal process. | ||
(b) During the period of time that the waiver program is | ||
considered a pilot program, pediatric palliative care shall be | ||
included in the issues reviewed by the Hospice and Palliative | ||
Care Advisory Board. The Board shall make recommendations | ||
regarding changes or improvements to the program, including but |
not limited to advisement on potential expansion of the | ||
potentially life-limiting medical conditions as defined in | ||
subsection (b) of Section 25. | ||
(c) At the end of the 3-year pilot program, the Department | ||
shall prepare a report for the General Assembly concerning the | ||
program's outcomes effectiveness and shall also make | ||
recommendations for program improvement, including, but not | ||
limited to, the appropriateness of the potentially | ||
life-limiting medical conditions as defined in subsection (b) | ||
of Section 25. | ||
Section 50. Effect on medical assistance program. | ||
(a) Nothing in this Act shall be construed so as to result | ||
in the elimination or reduction of any benefits or services | ||
covered under the medical assistance program under Article V of | ||
the Illinois Public Aid Code. | ||
(b) This Act does not affect an individual's eligibility to | ||
receive, concurrently with the benefits provided for in this | ||
Act, any services, including home health services, for which | ||
the individual would have been eligible in the absence of this | ||
Act.
| ||
Section 90. The Hospice Program Licensing Act is amended by | ||
changing Section 15 as follows: | ||
(210 ILCS 60/15) |
Sec. 15. Hospice and Palliative Care Advisory Board. | ||
(a) The Director shall appoint a Hospice and Palliative | ||
Care Advisory Board ("the Board") to consult with the | ||
Department as provided in this Section. The membership of the | ||
Board shall be as follows: | ||
(1) The Director, ex officio, who shall be a nonvoting | ||
member and shall serve as chairman of the Board. | ||
(2) One representative of each of the following State | ||
agencies, each of whom shall be a nonvoting member: the | ||
Department of
Healthcare and Family Services, the | ||
Department of Human Services, and the Department on Aging. | ||
(3) One member who is a physician licensed to
practice | ||
medicine in all its branches, selected from the | ||
recommendations of a statewide professional society | ||
representing physicians licensed to practice medicine in | ||
all its branches in all specialties. | ||
(4) One member who is a registered nurse,
selected from | ||
the recommendations of professional nursing associations. | ||
(5) Four members selected from the
recommendations of | ||
organizations whose primary membership consists of hospice | ||
programs. | ||
(6) Two members who represent the general
public and | ||
who have no responsibility for management or formation of | ||
policy of a hospice program and no financial interest in a | ||
hospice program. | ||
(7) One member selected from the
recommendations of |
consumer organizations that engage in advocacy or legal | ||
representation on behalf of hospice patients and their | ||
immediate families. | ||
(b) Of the initial appointees, 4 shall serve for terms of 2 | ||
years, 4 shall serve for terms of 3 years, and 5 shall serve | ||
for terms of 4 years, as determined by lot at the first meeting | ||
of the Board. Each successor member shall be appointed for a | ||
term of 4 years. A member appointed to fill a vacancy before | ||
the expiration of the term for which his or her predecessor was | ||
appointed shall be appointed to serve for the remainder of that | ||
term. | ||
(c) The Board shall meet as frequently as the chairman | ||
deems necessary, but not less than 4 times each year. Upon the | ||
request of 4 or more Board members, the chairman shall call a | ||
meeting of the Board. A Board member may designate a | ||
replacement to serve at a Board meeting in place of the member | ||
by submitting a letter stating that designation to the chairman | ||
before or at the Board meeting. The replacement member must | ||
represent the same general interests as the member being | ||
replaced, as described in paragraphs (1) through (7) of | ||
subsection (a). | ||
(d) Board members are entitled to reimbursement for their | ||
actual expenses incurred in performing their duties. | ||
(e) The Board shall advise the Department on all aspects of | ||
the Department's responsibilities under this Act, including | ||
the format and content of any rules adopted by the Department |
on or after the effective date of this amendatory Act of the | ||
95th General Assembly. Any such rule or amendment to a rule | ||
proposed on or after the effective date of this amendatory Act | ||
of the 95th General Assembly, except an emergency rule adopted | ||
pursuant to Section 5-45 of the Illinois Administrative | ||
Procedure Act, that is adopted without obtaining the advice of | ||
the Board is null and void. If the Department fails to follow | ||
the advice of the Board with respect to a proposed rule or | ||
amendment to a rule, the Department shall, before adopting the | ||
rule or amendment to a rule, transmit a written explanation of | ||
the reason for its action to the Board. During its review of | ||
rules, the Board shall analyze the economic and regulatory | ||
impact of those rules. If the Board, having been asked for its | ||
advice with respect to a proposed rule or amendment to a rule, | ||
fails to advise the Department within 90 days, the proposed | ||
rule or amendment shall be considered to have been acted upon | ||
by the Board.
| ||
(f) The Board shall also review pediatric palliative care | ||
issues as provided in the Pediatric Palliative Care Act. | ||
(Source: P.A. 95-133, eff. 1-1-08.)
| ||
Section 99. Effective date. This Act takes effect upon | ||
becoming law.
|